Biotechniques. 2003 Jun;Suppl:16-20.

Examination of the computed molecular properties of compounds selected for clinical development.

Source

Array BioPharma, Boulder, CO, USA. Jim.Blake@arraybiopharma.com

Abstract

We have conducted a systematic evaluation of the calculated molecular properties of compounds in clinical development and have found that the development process selects for compounds that have certain computed physical properties. In particular, as the stage of development progresses, compounds that are advanced have lower calculated octanollwater partition coefficient (ClogP), polar surface area, and molecular weight. The findings of this study provide guidance for combinatorial library design and lead selection, which may enhance the chance for ultimate success in lead optimization.

PMID:: 12813900; [PubMed - indexed for MEDLINE]

MeSH Terms

LinkOut - more resources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Related citations

Is there a difference between leads and drugs? A historical perspective. [J Chem Inf Comput Sci. 2001]
Is there a difference between leads and drugs? A historical perspective.
Oprea TI, Davis AM, Teague SJ, Leeson PD. J Chem Inf Comput Sci. 2001 Sep-Oct; 41(5):1308-15.
Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors. [J Med Chem. 1997]
Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors.
Matter H. J Med Chem. 1997 Apr 11; 40(8):1219-29.
Similarity measures for rational set selection and analysis of combinatorial libraries: the Diverse Property-Derived (DPD) approach. [J Chem Inf Comput Sci. 1997]
Similarity measures for rational set selection and analysis of combinatorial libraries: the Diverse Property-Derived (DPD) approach.
Lewis RA, Mason JS, McLay IM. J Chem Inf Comput Sci. 1997 May-Jun; 37(3):599-614.
Review Virtual screening of virtual libraries. [Prog Med Chem. 2003]
Review Virtual screening of virtual libraries.
Green DV. Prog Med Chem. 2003; 41:61-97.
Review Chemical substructures in drug discovery. [Drug Discov Today. 2003]
Review Chemical substructures in drug discovery.
Merlot C, Domine D, Cleva C, Church DJ. Drug Discov Today. 2003 Jul 1; 8(13):594-602.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Examination of the computed molecular properties of compounds selected for clini...
Examination of the computed molecular properties of compounds selected for clinical development.
Biotechniques. 2003 Jun ;Suppl:16-20.

PubMed
Model predicting survival in stage I melanoma based on tumor progression.
Model predicting survival in stage I melanoma based on tumor progression.
J Natl Cancer Inst. 1989 Dec 20 ;81(24):1893-904.

PubMed
How does HIV cause AIDS?
How does HIV cause AIDS?
Science. 1993 May 28 ;260(5112):1273-9.

PubMed
Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate lev...
Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats.
J Neurochem. 1997 Mar ;68(3):1326-9.

PubMed
Observer variation in the measurement of Breslow depth and Clark's level in thin...
Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma.
J Pathol. 1991 Mar ;163(3):245-50.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Examination of the computed molecular properties of compounds selected for clinical development.

Source

Abstract

MeSH Terms

MeSH Terms

LinkOut - more resources

Other Literature Sources

Supplemental Content

Related citations

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information